Guoke Xingan key facts
- Manufacturer of a high-end molecular diagnostic instrument and reagents intended to advance precision testing in healthcare.
- Notable investors include First Capital Investment Management Co., Shenzhen Yuanshan Private Equity Investment Management.
- Status: Privately Held (backing).
- ·Watch Guoke Xingan: the Monday email on marks, rounds and moves
Guoke Xingan funding rounds
No funding rounds for Guoke Xingan are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Guoke Xingan investors
2 investors are on record for Guoke Xingan, including First Capital Investment Management Co. and Shenzhen Yuanshan Private Equity Investment Management.
About Guoke Xingan
Manufacturer of a high-end molecular diagnostic instrument and reagents intended to advance precision testing in healthcare. The company offers integrated instrumentation, dedicated reagents and automated workflows, enabling clinical laboratories and diagnostic service providers to deliver more reliable, rapid and scalable molecular diagnostics.
- Sector
- Healthcare
- HQ
- Suzhou, China
- Founded
- 2016
- Website
- casens.cn/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Guoke Xingan doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.